Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HCA HealthcareHCA +1.56%86 3-Year EBITDA Growth Rate is 13.00% as of Jun. 2026, which is 7% above its 10-year median of 12.10. GuruFocus rates HCA with a GF Score™ of 86/100 and a GF Value™ of $460.64 (Fairly Valued). The stock has 2 warning signs investors should review. Among 526 Healthcare Providers & Services companies, HCA Healthcare ranks better than 55.89% on this metric.
During the past 12 months, HCA Healthcare's average EBITDA Per Share Growth Rate was 21.10% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 13.00% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 14.70% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 13.50% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of HCA Healthcare was 76.10% per year. The lowest was -40.40% per year. And the median was 12.10% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
HCA Healthcare 3-Year EBITDA Growth Rate Related Terms
HCA vs THC, EHC, DVA: 3-Year EBITDA Growth Rate Comparison
For the Medical Care Facilities subindustry, HCA Healthcare's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HCA Healthcare 3-Year EBITDA Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, HCA Healthcare's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where HCA Healthcare's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 13.00% mean?
HCA Healthcare (HCA) has a 3-Year EBITDA Growth Rate of 13.00% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for HCA Healthcare and its competitors. This is near median its historical median of 12.10. According to the industry distribution chart, HCA Healthcare ranks #232 out of 526 companies in the Healthcare Providers & Services industry, placing it in the top 44.1%.
Is HCA Healthcare's 3-Year EBITDA Growth Rate too high?
HCA Healthcare's current 3-Year EBITDA Growth Rate of 13.00% is near median its 10-year median of 12.10. The Healthcare Providers & Services industry median 3-Year EBITDA Growth Rate is 10.05. HCA Healthcare's value of 13.00% is 29.4% above this industry median. Based on the distribution chart, HCA Healthcare ranks #232 out of 526 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, HCA Healthcare has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does HCA Healthcare's 3-Year EBITDA Growth Rate compare to THC and EHC?
According to the Healthcare Providers & Services industry distribution chart, HCA Healthcare ranks #232 out of 526 companies for 3-Year EBITDA Growth Rate. This puts HCA Healthcare in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 10.05. HCA Healthcare's value of 13.00% is 29.4% above this benchmark. While the company's 10-year median is 12.10 vs. the industry median of 10.05, HCA Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Healthcare Providers & Services company?
The median 3-Year EBITDA Growth Rate among Healthcare Providers & Services companies is 10.05, based on 526 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HCA Healthcare's current 3-Year EBITDA Growth Rate of 13.00% is 29.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for HCA Healthcare and its competitors. For the Healthcare Providers & Services industry, the median 3-Year EBITDA Growth Rate is 10.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HCA Healthcare's current 3-Year EBITDA Growth Rate is 13.00%, which is near median its own 10-year median of 12.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HCA Healthcare stock overvalued right now?
Based on GuruFocus' analysis, HCA Healthcare (HCA) is currently considered Fairly Valued. The stock's GF Value™ is $460.64, compared to a current price of $430.43 — trading 6.6% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 13.00%, which is near median its 10-year median of 12.10 and 29.4% above the Healthcare Providers & Services industry median of 10.05. HCA Healthcare's overall GF Score™ is 86/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For HCA Healthcare (HCA), the current 3-Year EBITDA Growth Rate is 13.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is HCA Healthcare (HCA) Overvalued in 2026?
Based on GuruFocus' analysis, HCA Healthcare stock appears to be undervalued.
The current stock price of $430.43 is trading 6.6% below its estimated GF Value™ of $460.64.
GuruFocus considers HCA Healthcare to be Fairly Valued.
Key valuation signals for HCA:
3-Year EBITDA Growth Rate: 13.00% (near median its 10-year median of 12.10)
GF Value™: $460.64 vs. price of $430.43 (6.6% below fair value)
Industry Position: 29.4% above the Healthcare Providers & Services median (#232 of 526)
No single metric tells the full story. See the HCA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2025, the firm owned and operated 190 hospitals and over 2,500 outpatient facillities across 19 states and a small foothold in the United Kingdom.
86GF Score
Get the complete analysis for HCA
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HCA has been successfully added to your 
